
Dr. Reddy’s Q1 net inches up amid decline in generics sales to U.S.
The Hindu
Dr. Reddy’s Labs Q1 net profit rises slightly despite U.S. market decline, focus on strengthening base business.
More Related News

The U.S. has launched two investigations under Section 301 of the Trade Act of 1974 against India and other economies to examine practices that may be ‘unreasonable or discriminatory and burden or restrict U.S. commerce’. One probe examines whether countries, including India, are using excess manufacturing capacity to export to the U.S. in a manner that hurts American businesses, while another looks at whether countries have taken ‘sufficient steps’ to prohibit imports of goods produced with forced labour.












